4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-25-005237
EVP Research & Development sold 2,000 shares at $45.98 ($91,960)
- EVP Research & Development acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Malik Fady Ibraham EVP Research & Development | 2025-02-18 | Option exercise 10b5-1 | +2,000 | $10.60 | $21,200 | 118,071 | D |
| Malik Fady Ibraham EVP Research & Development | 2025-02-18 | Sale 10b5-1 | −2,000 | $45.98 | $91,960 | 116,071 | D |
| Derivatives | |||||||
| Malik Fady Ibraham EVP Research & Development | 2025-02-18 | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −2,000 | 33,105 | D | ||
| Open-market sales · 2,000 sh · avg $45.98 · $91,960 | |||||||
Loading xslF345X05/form4.xml…